Moomoo AI 已提取核心信息
Panbela Therapeutics, Inc., represented by ROTH CAPITAL PARTNERS, LLC, has formally requested the U.S. Securities and Exchange Commission (SEC) to declare its Registration Statement on Form S-1 effective at 5:30 p.m. Eastern time on January 25, 2024. This request, made under Rule 461 of the Securities Act of 1933, aims for the Registration Statement to be effective as soon as possible after the specified time. Additionally, in compliance with Rule 460, ROTH CAPITAL PARTNERS has distributed the Preliminary Prospectus dated January 25, 2024, to ensure adequate distribution. The placement agent also confirms adherence to Rule 15c2-8 under the Securities Exchange Act of 1934.
Panbela Therapeutics, Inc., represented by ROTH CAPITAL PARTNERS, LLC, has formally requested the U.S. Securities and Exchange Commission (SEC) to declare its Registration Statement on Form S-1 effective at 5:30 p.m. Eastern time on January 25, 2024. This request, made under Rule 461 of the Securities Act of 1933, aims for the Registration Statement to be effective as soon as possible after the specified time. Additionally, in compliance with Rule 460, ROTH CAPITAL PARTNERS has distributed the Preliminary Prospectus dated January 25, 2024, to ensure adequate distribution. The placement agent also confirms adherence to Rule 15c2-8 under the Securities Exchange Act of 1934.
由ROTH CAPITAL PARTNERS, LLC代表的Panbela Therapeutics, Inc. 已正式要求美国证券交易委员会（SEC）宣布其S-1表格的注册声明于美国东部时间2024年1月25日下午5点30分生效。该请求是根据1933年《证券法》第461条提出的，旨在使注册声明在规定时间后尽快生效。此外，根据第460条，ROTH CAPITAL PARTNERS已分发了2024年1月25日的初步招股说明书，以确保充分分配。配售机构还确认遵守1934年《证券交易法》第15c2-8条。
由ROTH CAPITAL PARTNERS, LLC代表的Panbela Therapeutics, Inc. 已正式要求美国证券交易委员会（SEC）宣布其S-1表格的注册声明于美国东部时间2024年1月25日下午5点30分生效。该请求是根据1933年《证券法》第461条提出的，旨在使注册声明在规定时间后尽快生效。此外，根据第460条，ROTH CAPITAL PARTNERS已分发了2024年1月25日的初步招股说明书，以确保充分分配。配售机构还确认遵守1934年《证券交易法》第15c2-8条。
有用
没用
